Servicio de Farmacia, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Departamento de Farmacología, Facultad de Farmacia, Universidad Complutense, Madrid, Spain.
Eur J Clin Pharmacol. 2019 Dec;75(12):1739-1746. doi: 10.1007/s00228-019-02757-3. Epub 2019 Sep 16.
RATIONALE, AIMS, AND OBJECTIVE: Traumatological patients are vulnerable to medication error given multiple handoffs throughout the hospital since they often require rapid diagnosis and management of multiple concurrent complex conditions. The purpose of this study was to analyze the medication errors (MEs) occurring in the care transition of the traumatological patient. The secondary objectives were to classify the MEs and the level of risk of the pharmacological groups involved. In addition, the causes and contributing factors of those MEs were analyzed.
An observational, descriptive, and prospective study, spanning 4 months, was performed in a tertiary hospital. All patients admitted to the traumatology service were selected for the study. Data were collected in different locations of the hospital stay: Emergency Service, Resuscitation and Post-Anaesthesia Unit, and Traumatology Hospitalization Unit. In each location, data from the different processes (reconciliation, prescription, validation, dispensing, and administration of medicines) were collected. The medication error (ME) was established as a dependent variable.
A total of 31.3% (132) of the patients analyzed showed some ME. The Traumatology Unit was the location where most errors were detected, followed by the Emergency Service. Having analyzed all the locations, it was observed that 64.2% (172) of the MEs were detected in the reconciliation process, 29.5% (79) in the prescription, 3.7% (10) in the dispensing, 1.5% (4) in the administration, and 1.1% (3) in the validation. In terms of risk weighting, the drugs involved in the MEs detected were 53.8% of medium risk, 20.7% of high risk, and 20.3% of low risk.
There is a high prevalence of MEs in the reconciliation process of medication in traumatological patients (64.2%) from our hospital setting. Interestingly, most MEs occurred in this process regardless of the location in the healthcare chain.
背景、目的和目标:由于创伤患者在医院中经常需要快速诊断和管理多种并发的复杂病情,因此在整个医院的多次交接过程中,他们容易发生用药错误。本研究的目的是分析创伤患者交接过程中发生的用药错误(ME)。次要目标是对涉及的 ME 进行分类,并对药理组的风险级别进行分类。此外,还分析了这些 ME 的原因和促成因素。
在一家三级医院进行了为期 4 个月的观察性、描述性和前瞻性研究。所有收入创伤科的患者均被选为研究对象。数据在医院住院的不同地点收集:急诊室、复苏和麻醉后病房以及创伤科住院病房。在每个地点,从不同流程(核对、处方、验证、配药和给药)中收集数据。将用药错误(ME)作为因变量。
分析的 31.3%(132 例)患者出现了某种 ME。在创伤科病房发现了最多的错误,其次是急诊室。分析所有地点后发现,64.2%(172 例)的 ME 发生在核对过程中,29.5%(79 例)发生在处方过程中,3.7%(10 例)发生在配药过程中,1.5%(4 例)发生在给药过程中,1.1%(3 例)发生在验证过程中。就风险加权而言,所涉及的 ME 药物有 53.8%为中度风险,20.7%为高度风险,20.3%为低度风险。
从我们的医院环境来看,创伤患者在药物核对过程中(64.2%)存在高频率的 ME。有趣的是,无论在医疗保健链的哪个位置,大多数 ME 都发生在这个过程中。